Tatsuaki Sumiyoshi Yasuo Shima Takehiro Okabayashi Akihito Kozuki Jun Iwata Yuichi Saisaka Teppei Tokumaru Toshio Nakamura Sojiro Morita
10.1097/MD.0000000000000378
Medicine (Baltimore)
2015 Jan;94(1):e378.
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25569665/
Antimetabolites, Antineoplastic / therapeutic use Carcinoma, Acinar Cell / surgery Oxonic Acid / therapeutic use Pancreatic Neoplasms / surgery Tegafur / therapeutic use
Antimetabolites, Antineoplastic / therapeutic use Carcinoma, Acinar Cell / surgery Oxonic Acid / therapeutic use Pancreatic Neoplasms / surgery Tegafur / therapeutic use Case Reports Review Aged Carcinoma, Acinar Cell / drug therapy Carcinoma, Acinar Cell / pathology Drug Combinations Humans Male Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / pathology Peritoneum / pathology Antimetabolites, Antineoplastic Drug Combinations S 1 (combination) Tegafur Oxonic Acid
PMC4602841
25569665
Long-term survival following pancreatectomy and s-1 chemotherapy for pancreatic acinar cell carcinoma with peritoneal dissemination: a case report and literature review
2015